Results 141 to 150 of about 4,918,610 (234)

Major Bleeding During Factor Xa Inhibitor Therapy: Lessons from the Pre-Andexanet Era in Japan. [PDF]

J Atheroscler Thromb
Minami M.
europepmc   +1 more source

Modeling the Clinical Implications of Andexanet Alfa in Factor Xa Inhibitor-Associated Intracerebral Hemorrhage. [PDF]

Neurology, 2021
Chuck CC, Kim D, Kalagara R, Rex N, Madsen TE, Mahmoud L, Thompson BB, Jones RN, Furie KL, Reznik ME.   +9 more
europepmc   +1 more source

Impact of a factor Xa inhibitor (apixaban) on SIV pathogenesis and response to antiretroviral therapy. [PDF]

JCI Insight
Xu C, Annapureddy H, Carson L, Khurana V, Sivanandham R, Sivanandham S, He T, Raehtz KD, Kim J, Biber C, Arbujas-Silva N, Daira M, Kandasamy S, Feinstein MJ, Sereti I, Apetrei C, Pandrea I.   +16 more
europepmc   +1 more source

Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. [PDF]

J Thromb Thrombolysis, 2023
Sutton SS, Magagnoli J, Cummings TH, Dettling T, Lovelace B, Christoph MJ, Hardin JW.   +6 more
europepmc   +1 more source

Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing. [PDF]

Res Pract Thromb Haemost, 2023
Chiasakul T, Crowther M, Cuker A.
europepmc   +1 more source

Prothrombin complex concentrate for oral factor Xa inhibitor reversal prior to urgent invasive procedures. [PDF]

Transfusion
Shamiea M, Osnis A, Kashoua A, Avnery O, Itchaki G, Isman S, Tohami T, Jarchowsky-Dolberg O, Ellis M.   +8 more
europepmc   +1 more source

Correction to: Real-world clinical outcomes among US Veterans with oral factor xa inhibitor-related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate. [PDF]

J Thromb Thrombolysis, 2023
Sutton SS, Magagnoli J, Cummings TH, Dettling T, Lovelace B, Christoph MJ, Hardin JW.   +6 more
europepmc   +1 more source

Prothrombin complex concentrate for oral factor Xa inhibitor-associated intracerebral hemorrhage. [PDF]

Res Pract Thromb Haemost
Shamiea M, Sbehi H, Rashed NA, Kashua A, Fanadka F, Rabina E, Osnis A, Itchaki G, Avnery O, Jarchowsky-Dolberg O, Ellis M.   +10 more
europepmc   +1 more source

Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa-PAR2-Mediated Autophagy Suppression. [PDF]

JACC Basic Transl Sci, 2021
Ito Y, Maejima Y, Nakagama S, Shiheido-Watanabe Y, Tamura N, Sasano T.   +5 more
europepmc   +1 more source

Andexanet Alfa for Life-Threatening Bleeding Following Factor Xa Inhibitor Treatment: Postmarketing Surveillance Study in Japan. [PDF]

JACC Asia
Sakamoto K, Ishihara M, Kato H, Kim H, Okuda M, Hiroki S, Koga M, Toyoda K.   +7 more
europepmc   +1 more source